Two studies hail resveratrol type 2 diabetes potential

By Annie-Rose Harrison-Dunn

- Last updated on GMT

“Newer treatments are required to complement and enhance the efficacy of existing diabetic regimen," say researchers.
“Newer treatments are required to complement and enhance the efficacy of existing diabetic regimen," say researchers.

Related tags Diabetes mellitus

Supplemental resveratrol should be considered as an adjunct to standard anti-diabetic agents in the treatment of type 2 diabetes, according to two studies conducted at the University of Medical Sciences in Iran and JSS University in India.

Resveratrol is a polyphenol and anti-fungal antioxidant most typically sourced from grapes and red wine.

The JSS University, India

57 participants with type 2 diabetes (T2DM) were given either oral hypoglycemic agents in the control group or resveratrol (250mg/day) and oral hypoglycemic agents in the intervention group over a period of six months.

“Our central findings are that oral supplementation of resveratrol along with antidiabetic agents is effective in improving vascular risk factors, namely body weight, oxidative stress and lipid profile in type 2 diabetic patients,”​ professor Moola Joghee Nanjan told NutraIngredients.

“The practical implications of these findings are that type 2 diabetic patients are known to be more sensitive to the deterioration in their quality of life because of the chronic disease, related complications, alternative treatment, diet restriction and lifelong treatment with tablets or insulin.  Supplementation of resveratrol is expected to improve their quality of life."

Existing type 2 diabetes (T2DM) treatments limit their use because of side effects like weight gain, hypoglycaemia and contraindications. Furthermore, current anti-diabetic treatments do not have any significant impact on associated risk factors, claim the JSS University researchers.

“There is a need, therefore, for new therapies that may improve not only hyperglycaemic effect but also the associated problems,” ​the researchers wrote. “Resveratrol could, therefore, be used as an effective adjuvant therapy with conventional hyperglycemic regimen for the management of diabetes.”

The University of Medical Sciences, Iran

The objective of the Iranian study was to examine the effectiveness of resveratrol in lowering blood glucose in conjunction with standard anti-diabetic treatment of type 2 patients in a randomised, placebo-controlled, double-blinded parallel clinical trial.

The research involved 66 participants with T2DM randomly assigned to either an intervention resveratrol supplemented group (1 g/day for 45 days) or a control group which received placebo tablets.

“The central findings of the study was that supplementation of resveratrol (along with standard anti-diabetic medication) for a short term is beneficial in lowering blood glucose and insulin in patients with type 2 diabetes,”​ Dr Ali Movahed told NutraIngredients.

“If future trials also confirm the positive outcomes observed in our study, resveratrol could become an adjunct in diabetic medicine​. “Newer treatments are required to complement and enhance the efficacy of existing diabetic regimen.”

The most recent epidemiological data from the International Diabetes Federation (IDF) showed that diabetes affects around 371m people globally, of which 4.8m die every year. This latter study noted that the Islamic Republic of Iran is one of the countries having the highest prevalence of T2DM. The study outlined also that developing countries will make up 77.6% of those affected by 2030.

Source: International Research Journal of Pharmacy

Vol. 2013, Iss. 4, pp. 245-249, doi: 10.7897/2230-8407.04849

“Resveratrol Supplementation in Patients with Type 2 Diabetes Mellitus: A Prospective, Open Label, Randomized Controlled Trial”

Authors: B.J. Kumar, M.J. Nanjan

Source: Evidence-Based Complementary and Alternative Medicine

Vol. 2013, doi:10.1155/2013/851267 

“Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients”

Authors: A. Movahed, I. Nabipour, X.L Louis, et al.

Related news

Show more

Related products

show more

Sweetening solution for active nutrition

Sweetening solution for active nutrition

Content provided by ADM | 19-Feb-2024 | Case Study

When you add GrainSweet® Liquid Maltodextrin to your active nutrition applications, you get the production efficiencies, clean labels, and clean tastes...

Related suppliers


Resveratrol Supplements improves Blood Pressure and Diabetes

Posted by Dr.Anthony Hanks,

This is asurprising result and means that all doctors who treat diabetics with Drugs should also prescribe resveratrol supplements to get maximum benefit.
It also improved Cholesterol by increasing HDL and lowering LDL.
Study used transmax and only took 2 months to get results with no side effects.

Report abuse

Biotivia Studies

Posted by J Betz,

Both of these studies were done with Biotivia resveratrol. The first one, which is the most authoritative yet on Type 2 Diabetes, used Transmax and the India study, the second to confirm the benefits of adding Bioforte to the existing glucose management regimen, used Bioforte. It is Interesting that Nutraingredients did not mention this fact, since it is clearly stated in the original releases by the investigators that the studies used Biotivia RSV. Clearly Biotivia has become the default brand of resveratrol for use in human clinical trials. Several new studies will be released prior to the end of this year on other pathologies, including the first clinical trial on cancer by a major medical school.

What is also worth noting is that in the first study Transmax attenuated not only serum glucose levels, but also blood pressure, LDL cholesterol, and body weight, while beneficially modulating HDL cholesterol.

Report abuse

Follow us


View more